Journal for ImmunoTherapy of Cancer,
Год журнала:
2019,
Номер
7(1)
Опубликована: Окт. 17, 2019
The
implementation
of
immune
checkpoint
inhibitors
to
the
oncology
clinic
signified
a
new
era
in
cancer
treatment.
After
first
indication
melanoma,
an
increasing
list
additional
types
are
now
treated
with
system
targeting
antibodies
PD-1,
PD-L1
and
CTLA-4,
alleviating
inhibition
signals
on
T
cells.
Recently,
we
published
proof-of-concept
results
novel
inhibitor,
NKG2A.
This
receptor
is
expressed
cytotoxic
lymphocytes,
including
NK
cells
subsets
activated
CD8+
Blocking
NKG2A
unleashed
reactivity
these
effector
resulting
tumor
control
multiple
mouse
models
early
clinical
trial.
Monalizumab
inhibiting
this
human
beings
future
trials
will
have
reveal
its
potency
combination
other
treatment
options.
European Journal of Immunology,
Год журнала:
2019,
Номер
49(10), С. 1457 - 1973
Опубликована: Окт. 1, 2019
These
guidelines
are
a
consensus
work
of
considerable
number
members
the
immunology
and
flow
cytometry
community.
They
provide
theory
key
practical
aspects
enabling
immunologists
to
avoid
common
errors
that
often
undermine
immunological
data.
Notably,
there
comprehensive
sections
all
major
immune
cell
types
with
helpful
Tables
detailing
phenotypes
in
murine
human
cells.
The
latest
techniques
applications
also
described,
featuring
examples
data
can
be
generated
and,
importantly,
how
analysed.
Furthermore,
tips,
tricks
pitfalls
avoid,
written
peer-reviewed
by
leading
experts
field,
making
this
an
essential
research
companion.
Nature Communications,
Год журнала:
2018,
Номер
9(1)
Опубликована: Июль 9, 2018
Abstract
Identifying
tumor
antigen-specific
T
cells
from
cancer
patients
has
important
implications
for
immunotherapy
diagnostics
and
therapeutics.
Here,
we
show
that
CD103
+
CD39
tumor-infiltrating
CD8
(CD8
TIL)
are
enriched
tumor-reactive
both
in
primary
metastatic
tumors.
This
TIL
subset
is
found
across
six
different
malignancies
displays
an
exhausted
tissue-resident
memory
phenotype.
TILs
have
a
distinct
T-cell
receptor
(TCR)
repertoire,
with
clones
expanded
the
but
present
at
low
frequencies
periphery.
also
efficiently
kill
autologous
MHC-class
I-dependent
manner.
Finally,
higher
of
head
neck
associated
better
overall
survival.
Our
data
thus
describe
approach
detecting
will
help
define
mechanisms
existing
treatments,
may
lead
to
future
adoptive
therapies.
Signal Transduction and Targeted Therapy,
Год журнала:
2022,
Номер
7(1)
Опубликована: Март 24, 2022
Abstract
The
NOTCH
gene
was
identified
approximately
110
years
ago.
Classical
studies
have
revealed
that
signaling
is
an
evolutionarily
conserved
pathway.
receptors
undergo
three
cleavages
and
translocate
into
the
nucleus
to
regulate
transcription
of
target
genes.
deeply
participates
in
development
homeostasis
multiple
tissues
organs,
aberration
which
results
cancerous
noncancerous
diseases.
However,
recent
indicate
outcomes
are
changeable
highly
dependent
on
context.
In
terms
cancers,
can
both
promote
inhibit
tumor
various
types
cancer.
overall
performance
NOTCH-targeted
therapies
clinical
trials
has
failed
meet
expectations.
Additionally,
mutation
been
proposed
as
a
predictive
biomarker
for
immune
checkpoint
blockade
therapy
many
cancers.
Collectively,
pathway
needs
be
integrally
assessed
with
new
perspectives
inspire
discoveries
applications.
this
review,
we
focus
classical
latest
findings
related
illustrate
history,
architecture,
regulatory
mechanisms,
contributions
physiological
development,
diseases,
therapeutic
applications
microenvironment
cancer
immunotherapy
also
highlighted.
We
hope
review
will
help
not
only
beginners
but
experts
systematically
thoroughly
understand
Nature Communications,
Год журнала:
2019,
Номер
10(1)
Опубликована: Окт. 17, 2019
Human
T
cells
coordinate
adaptive
immunity
in
diverse
anatomic
compartments
through
production
of
cytokines
and
effector
molecules,
but
it
is
unclear
how
tissue
site
influences
cell
persistence
function.
Here,
we
use
single
RNA-sequencing
(scRNA-seq)
to
define
the
heterogeneity
human
isolated
from
lungs,
lymph
nodes,
bone
marrow
blood,
their
functional
responses
following
stimulation.
Through
analysis
>50,000
resting
activated
cells,
reveal
signatures
mucosal
lymphoid
sites,
lineage-specific
activation
states
across
all
sites
including
distinct
for
CD8+
an
interferon-response
state
CD4+
cells.
Comparing
scRNA-seq
profiles
tumor-associated
our
dataset
reveals
predominant
compared
within
multiple
tumor
types.
Our
results
therefore
establish
a
high
dimensional
reference
map
health
analyzing
disease.
Science Immunology,
Год журнала:
2019,
Номер
4(34)
Опубликована: Апрель 5, 2019
The
discovery
of
T
cells
resident
in
diverse
tissues
has
altered
our
understanding
adaptive
immunity
to
encompass
site-specific
responses
mediated
by
tissue-adapted
memory
throughout
the
body.
Here,
we
discuss
key
phenotypic,
transcriptional,
and
functional
features
these
tissue-resident
(TRM)
as
established
mouse
models
infection
translated
humans
novel
tissue
sampling
approaches.
Integration
findings
from
human
studies
may
hold
unlocking
potential
TRM
for
promoting
preventing
infection.